Form 4: Rockwell Medical Director Radie Receives Restricted Stock Units

Robert S. Radie, a director at Rockwell Medical, Inc., acquired 36,111 shares of common stock in the form of restricted stock units on May 21, 2024.

Summary

• On May 21, 2024, Robert S. Radie, a director at Rockwell Medical, Inc., acquired 36,111 shares of common stock in the form of restricted stock units.
• These restricted stock units were granted at a price of $0 per share.
• Following the transaction, Radie directly owns 93,525 shares of Rockwell Medical common stock.
• The restricted stock units vest on May 21, 2025, contingent upon Radie's continued service to the company.
• The filing also includes an exhibit for a Power of Attorney, effective February 1, 2024, authorizing Mark Strobeck, Megan Timmins, and Ryan Murr to file Section 16 documents on Radie's behalf.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock units granted to a director. The grant itself could be seen as a positive, but the filing is primarily informational.

Positives

• The acquisition of restricted stock units by a director could be seen as a positive sign, aligning the director's interests with those of the shareholders.

Future Outlook

The restricted stock units vest on May 21, 2025, contingent upon the director's continued service.

Industry Context

This is a standard SEC Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the alignment of director and shareholder interests.

Key Dates